AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
CARDIAC-HYPERTROPHY AND HYPERTENSION
Authors: AGABITIROSEI E MUIESAN ML
Citation: E. Agabitirosei et Ml. Muiesan, CARDIAC-HYPERTROPHY AND HYPERTENSION, Current opinion in nephrology and hypertension, 7(2), 1998, pp. 211-216
RELATIONS BETWEEN CARDIAC AND VASCULAR STRUCTURE IN PATIENTS WITH PRIMARY AND SECONDARY HYPERTENSION
Authors: RIZZONI D MUIESAN ML PORTERI E SALVETTI M CASTELLANO M BETTONI G TIBERIO G GIULINI SM MONTEDURO C GARAVELLI G AGABITIROSEI E
Citation: D. Rizzoni et al., RELATIONS BETWEEN CARDIAC AND VASCULAR STRUCTURE IN PATIENTS WITH PRIMARY AND SECONDARY HYPERTENSION, Journal of the American College of Cardiology, 32(4), 1998, pp. 985-992
VARIOUS WAYS OF CALCULATING ECHOCARDIOGRAPHIC LEFT-VENTRICULAR MASS AND THEIR RELATIVE PROGNOSTIC VALUES
Authors: MUIESAN ML SALVETTI M MONTEDURO C DONATO F RIZZONI D AGABITIROSEI E
Citation: Ml. Muiesan et al., VARIOUS WAYS OF CALCULATING ECHOCARDIOGRAPHIC LEFT-VENTRICULAR MASS AND THEIR RELATIVE PROGNOSTIC VALUES, Journal of hypertension, 16(8), 1998, pp. 1201-1206
IMPROVEMENT OF MIDWALL SYSTOLIC PERFORMANCE AFTER REGRESSION OF LVH AND WITHDRAWAL OF TREATMENT
Authors: MUIESAN ML SALVETTI M ZULLI R RIZZONI D MONTEDURO C BRUN C FRANZONI P CORBELLINI C AGABITIROSEI E
Citation: Ml. Muiesan et al., IMPROVEMENT OF MIDWALL SYSTOLIC PERFORMANCE AFTER REGRESSION OF LVH AND WITHDRAWAL OF TREATMENT, Journal of hypertension, 16, 1998, pp. 145-145
EFFECT OF ANTIHYPERTENSIVE TREATMENT ON FLOW-DEPENDENT VASODILATATIONOF BRACHIAL-ARTERY IN ESSENTIAL-HYPERTENSION
Authors: MUIESAN ML SALVETTI M MONTEDURO C RIZZONI D ZULLI R BRUN C BETTONI G CORBELLINI C AGABITIROSEI E
Citation: Ml. Muiesan et al., EFFECT OF ANTIHYPERTENSIVE TREATMENT ON FLOW-DEPENDENT VASODILATATIONOF BRACHIAL-ARTERY IN ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 1118-1118
LEFT-VENTRICULAR HYPERTROPHY - HOW TO INFLUENCE AN IMPORTANT RISK FACTOR IN HYPERTENSION
Authors: AGABITIROSEI E MUIESAN ML
Citation: E. Agabitirosei et Ml. Muiesan, LEFT-VENTRICULAR HYPERTROPHY - HOW TO INFLUENCE AN IMPORTANT RISK FACTOR IN HYPERTENSION, Journal of hypertension, 16, 1998, pp. 53-58
FLOW-DEPENDENT VASODILATATION OF BRACHIAL-ARTERY AND THE EFFECT OF ANTIHYPERTENSIVE TREATMENT IN ESSENTIAL HYPERTENSIVE PATIENTS
Authors: MUIESAN L SALVETTI M MONTEDURO C RIZZONI D ZULLI R BRUN C CORBELLINI C AGABITIROSEI E
Citation: L. Muiesan et al., FLOW-DEPENDENT VASODILATATION OF BRACHIAL-ARTERY AND THE EFFECT OF ANTIHYPERTENSIVE TREATMENT IN ESSENTIAL HYPERTENSIVE PATIENTS, Hypertension, 32(4), 1998, pp. 304-304
FLOW-DEPENDENT VASODILATATION OF BRACHIAL-ARTERY IN ESSENTIAL-HYPERTENSION - EFFECT OF ANTIHYPERTENSIVE TREATMENT
Authors: MUIESAN ML SALVETTI M MONTEDURO C RIZZONI D ZULLI R BRUN C BETTONI G CORBELLINI C AGABITIROSEI E
Citation: Ml. Muiesan et al., FLOW-DEPENDENT VASODILATATION OF BRACHIAL-ARTERY IN ESSENTIAL-HYPERTENSION - EFFECT OF ANTIHYPERTENSIVE TREATMENT, Hypertension, 32(3), 1998, pp. 22-22
ENDOTHELIAL DYSFUNCTION IN HYPERTENSION IS INDEPENDENT FROM THE ETIOLOGY AND FROM VASCULAR STRUCTURE
Authors: RIZZONI D PORTERI E CASTELLANO M BETTONI G MUIESAN ML TIBERIO G GIULINI SM ROSSI G BERNINI G AGABITIROSEI E
Citation: D. Rizzoni et al., ENDOTHELIAL DYSFUNCTION IN HYPERTENSION IS INDEPENDENT FROM THE ETIOLOGY AND FROM VASCULAR STRUCTURE, Hypertension, 31(1), 1998, pp. 335-341
IMPROVEMENT OF MIDWALL SYSTOLIC PERFORMANCE AFTER REVERSAL OF CARDIAC-HYPERTROPHY IN HYPERTENSIVE PATIENTS
Authors: MUIESAN ML SALVETTI M MONTEDURO C ZULLI R RIZZONI D BRUN C CORBELLINI C AGABITIROSEI E
Citation: Ml. Muiesan et al., IMPROVEMENT OF MIDWALL SYSTOLIC PERFORMANCE AFTER REVERSAL OF CARDIAC-HYPERTROPHY IN HYPERTENSIVE PATIENTS, Circulation, 98(17), 1998, pp. 140-140
PHENYLEPHRINE-INDUCED EUTROPHIC VASCULAR REMODELING IS ABSENT IN ALPHA-1B-ADRENERGIC RECEPTOR-DEFICIENT MICE
Authors: LEMBO G VECCHIONE C RIZZONI D FRATTA L PORTERI E AGABITIROSEI E COTECCHIA S TRIMARCO B
Citation: G. Lembo et al., PHENYLEPHRINE-INDUCED EUTROPHIC VASCULAR REMODELING IS ABSENT IN ALPHA-1B-ADRENERGIC RECEPTOR-DEFICIENT MICE, Circulation, 98(17), 1998, pp. 4235-4235
EFFECTS OF VERAPAMIL SR, TRANDOLAPRIL, AND THEIR FIXED COMBINATION ON24-H BLOOD-PRESSURE - THE VERATRAN STUDY
Authors: MANCIA G AGABITIROSEI E BENETTI G CALCAGNINI G CAMPA PP CARRETTA R CASATI R COCA A DELASIERRA A FEDERIGHI G FOGARI R FONTANA S GOMEZ B INFELISE V NAMI R PASOTTI C PIRRELLI A OTERO L VIDAL L OMBONI S RAVOGLI A SANTUCCIU C ULIAN L
Citation: G. Mancia et al., EFFECTS OF VERAPAMIL SR, TRANDOLAPRIL, AND THEIR FIXED COMBINATION ON24-H BLOOD-PRESSURE - THE VERATRAN STUDY, American journal of hypertension, 10(5), 1997, pp. 492-499
PERSISTENCE OF LEFT-VENTRICULAR HYPERTROPHY IS A STRONGER INDICATOR OF CARDIOVASCULAR EVENTS THAN BASE-LINE LV MASS OR PERFORMANCE - A 10 YEARS FOLLOW-UP
Authors: MUIESAN ML SALVETTI M ZULLI R CASTELLANO M RIZZONI D CINELLI A PORTERI E CALEBICH S AGABITIROSEI E
Citation: Ml. Muiesan et al., PERSISTENCE OF LEFT-VENTRICULAR HYPERTROPHY IS A STRONGER INDICATOR OF CARDIOVASCULAR EVENTS THAN BASE-LINE LV MASS OR PERFORMANCE - A 10 YEARS FOLLOW-UP, Journal of the American College of Cardiology, 29(2), 1997, pp. 7663-7663
EFFECTS OF LONG-TERM ANTIHYPERTENSIVE TREATMENT WITH LISINOPRIL ON RESISTANCE ARTERIES IN HYPERTENSIVE PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY
Authors: RIZZONI D MUIESAN ML PORTERI E CASTELLANO M ZULLI R BETTONI G SALVETTI M MONTEDURO C AGABITIROSEI E
Citation: D. Rizzoni et al., EFFECTS OF LONG-TERM ANTIHYPERTENSIVE TREATMENT WITH LISINOPRIL ON RESISTANCE ARTERIES IN HYPERTENSIVE PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY, Journal of hypertension, 15(2), 1997, pp. 197-204
THE VASOCONSTRICTION INDUCED BY ENDOTHELIN-1 IS MEDIATED ONLY BY ETA RECEPTORS IN MESENTERIC SMALL RESISTANCE ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS AND WISTAR-KYOTO RATS
Authors: RIZZONI D PORTERI E PICCOLI A CASTELLANO M BETTONI G PASINI G AGABITIROSEI E
Citation: D. Rizzoni et al., THE VASOCONSTRICTION INDUCED BY ENDOTHELIN-1 IS MEDIATED ONLY BY ETA RECEPTORS IN MESENTERIC SMALL RESISTANCE ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS AND WISTAR-KYOTO RATS, Journal of hypertension, 15(12), 1997, pp. 1653-1657
ALPHA-ADDUCIN GENE POLYMORPHISM AND CARDIOVASCULAR PHENOTYPES IN A GENERAL-POPULATION
Authors: CASTELLANO M BARLASSINA C MUIESAN ML BESCHI M CINELLI A ROSSI F RIZZONI D CUSI D AGABITIROSEI E
Citation: M. Castellano et al., ALPHA-ADDUCIN GENE POLYMORPHISM AND CARDIOVASCULAR PHENOTYPES IN A GENERAL-POPULATION, Journal of hypertension, 15(12), 1997, pp. 1707-1710
REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY AS A SURROGATE END-POINT FOR MORBID EVENTS IN HYPERTENSION TREATMENT TRIALS (VOL 14, PG S95, 1996)
Authors: DEVEREUX RB AGABITIROSEI E DAHLOF B GOSSE P HAHN RT OKIN PM ROMAN MJ
Citation: Rb. Devereux et al., REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY AS A SURROGATE END-POINT FOR MORBID EVENTS IN HYPERTENSION TREATMENT TRIALS (VOL 14, PG S95, 1996), Journal of hypertension, 15(1), 1997, pp. 103-103
ENDOTHELIAL DYSFUNCTION IN HUMAN HYPERTENSION IS INDEPENDENT FROM THEETIOLOGY AND FROM VASCULAR STRUCTURE
Authors: RIZZONI D PORTERI E CASTELLANO M BETTONI G TIBENO G GIULINI SM AGABITIROSEI E
Citation: D. Rizzoni et al., ENDOTHELIAL DYSFUNCTION IN HUMAN HYPERTENSION IS INDEPENDENT FROM THEETIOLOGY AND FROM VASCULAR STRUCTURE, Hypertension, 30(3), 1997, pp. 194-194
AMBULATORY BLOOD-PRESSURE IS SUPERIOR TO CLINIC BLOOD-PRESSURE IN PREDICTING TREATMENT-INDUCED REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY (VOL 95, PG 1494, 1997)
Authors: MANCIA G ZANCHETTI A AGABITIROSEI E BENEMIO G DECESARIS R FOGARI R PESSINA A PORCELLATI C RAPPELLI A SALVETTI A TRIMARCO B
Citation: G. Mancia et al., AMBULATORY BLOOD-PRESSURE IS SUPERIOR TO CLINIC BLOOD-PRESSURE IN PREDICTING TREATMENT-INDUCED REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY (VOL 95, PG 1494, 1997), Circulation, 96(3), 1997, pp. 1065-1065
EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE HEART AND VESSELS IN CLINICAL AND EXPERIMENTAL-HYPERTENSION - A REVIEW
Authors: BRUNEL P AGABITIROSEI E
Citation: P. Brunel et E. Agabitirosei, EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE HEART AND VESSELS IN CLINICAL AND EXPERIMENTAL-HYPERTENSION - A REVIEW, Clinical drug investigation, 12(5), 1996, pp. 226-243
CARDIOVASCULAR CHARACTERISTICS IN NORMOTENSIVE SUBJECTS WITH OR WITHOUT FAMILY HISTORY OF HYPERTENSION
Authors: MUIESAN ML RIZZONI D ZULLI R CALEBICH S PASINI GF MATTEI P DILEGGE V VIRDIS A TADDEI S AGABITIROSEI E SALVETTI A
Citation: Ml. Muiesan et al., CARDIOVASCULAR CHARACTERISTICS IN NORMOTENSIVE SUBJECTS WITH OR WITHOUT FAMILY HISTORY OF HYPERTENSION, Clinical and experimental hypertension, 18(7), 1996, pp. 901-920
CARDIOVASCULAR STRUCTURAL ALTERATIONS IN HYPERTENSION - EFFECT OF TREATMENT
Authors: AGABITIROSEI E MUIESAN ML RIZZONI D
Citation: E. Agabitirosei et al., CARDIOVASCULAR STRUCTURAL ALTERATIONS IN HYPERTENSION - EFFECT OF TREATMENT, Clinical and experimental hypertension, 18(3-4), 1996, pp. 513-522
PERSISTENCE OF LEFT-VENTRICULAR HYPERTROPHY IS A STRONGER INDICATOR OF CARDIOVASCULAR EVENTS THAN BASE-LINE LEFT-VENTRICULAR MASS OR SYSTOLIC PERFORMANCE - 10 YEARS OF FOLLOW-UP
Authors: MUIESAN ML SALVETTI M RIZZONI D MONTEDURO C CASTELLANO M AGABITIROSEI E
Citation: Ml. Muiesan et al., PERSISTENCE OF LEFT-VENTRICULAR HYPERTROPHY IS A STRONGER INDICATOR OF CARDIOVASCULAR EVENTS THAN BASE-LINE LEFT-VENTRICULAR MASS OR SYSTOLIC PERFORMANCE - 10 YEARS OF FOLLOW-UP, Journal of hypertension, 14, 1996, pp. 43-49
THE OPTIMAL BLOOD-PRESSURE REDUCTION - DISCUSSION
Authors: FROHLICH ED RAHN KH HANSSON L SEVER PS AGABITIROSEI E ARAKAWA K LINDHOLM L
Citation: Ed. Frohlich et al., THE OPTIMAL BLOOD-PRESSURE REDUCTION - DISCUSSION, Journal of hypertension, 14, 1996, pp. 58-59
AMBULATORY BLOOD-PRESSURE MONITORING - DISCUSSION
Authors: MENARD J MANCIA G FROHLICH ED HAMET P AGABITIROSEI E ZANCHETTI A
Citation: J. Menard et al., AMBULATORY BLOOD-PRESSURE MONITORING - DISCUSSION, Journal of hypertension, 14, 1996, pp. 66-68
Risultati: 1-25 | 26-50 | 51-51